SCHEMBL2945569

SCHEMBL2945569

CN(Cc1ccc2c(c1)OC([N+](=O)[O-])O2)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
LMNA P02545 2/20 0.46
HPGD P15428 3/20 0.37
GAA P10253 1/20 0.37
TSHR P16473 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
HSP90AA1 P07900 1/20 0.36
CA12 O43570 1/20 0.36
CA9 Q16790 1/20 0.36
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
RIPK1 Q13546 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9392813 0.76 P2RY6 (0.41) ALDH1A1TSHRCA12CA9SMN1; SMN2
SCHEMBL11390038 0.73 HPGD (0.64) ALDH1A1HPGDGAATSHRMEN1
SCHEMBL4810294 0.71 CRHBP (0.61) ALDH1A1LMNATSHRSMN1; SMN2CYP1A2
SCHEMBL14798532 0.70 SMN1; SMN2 (0.63) ALDH1A1LMNAGAATSHRMEN1
Methane SCHEMBL3489699 0.70 ALDH1A1 (0.41) ALDH1A1TSHRMEN1KMT2ARAB9A
SCHEMBL31079746 0.69 CYP19A1 (0.45) ALDH1A1LMNAHPGD
SCHEMBL636947 0.68 DRD5 (0.31) CYP3A4
SCHEMBL12491462 0.68 SMN1; SMN2 (0.50) ALDH1A1LMNASMN1; SMN2
SCHEMBL26087008 0.67 ALDH1A1 (0.56) ALDH1A1HPGDTSHRMEN1KMT2A
SCHEMBL29003684 0.66 TSHR (0.49) ALDH1A1LMNAGAATSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3898613-A1 ANTICANCER COMPOUNDS Pharma Mar S.A. (ES) 2021-10-27 EP disclosed
WO-2020127194-A1 ANTICANCER COMPOUNDS PHARMA MAR, S.A. (ES) 2020-06-25 WO disclosed
WO-2010149688-A2 ANTITUMORAL COMPOUNDS PHARMA MAR, S.A. (ES) 2010-12-29 WO disclosed